GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human respiratory syncytial virus fusion glycoprotein inhibitor escape variant L141W stabilized in the prefusion state

Analyse Crystal structure of human respiratory syncytial virus fusion glycoprotein… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6EAE
Type
protein
Length
451 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Fusion glycoprotein F0
UniProt
W8RJF9
Ligands
SO4
Pockets
2 · best druggability 0.42

Structure

x-ray diffraction · 1 distinct chain · 30% helix, 33% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
FFusion glycoprotein F0protein45130% helix, 33% strandW8RJF9

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 5 copies · chains F
  • NHE · 2-[N-cyclohexylamino]ethane sulfonic acid · additive · 2 copies · chains F

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11320.420.7523empty
2640.360.7814empty

Modifications

Observed in the structure: 7 disulfide (disulfide).

Compared structures

  • 6EAE · Crystal structure of human respiratory syncytial virus fusion glycoprotein inhibitor… · the same entry in another collection · chain F against F, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.